Agilent Technologies (A) balance sheet and financial health
TrendArc score 65 of 100 · Health 7.9 · Momentum 7.9 · Moat 6.6 · scored Nov 17, 2026 · How the score works
Cash and short-term investments less borrowings, July 31, 2026
$2.2 billion more borrowings than cash
Agilent Technologies held $1.8 billion of cash and short-term investments against $3.9 billion of borrowings on July 31, 2026. Its lease liabilities, shown apart from borrowings, were $199 million. In the fiscal year to October 2025 its operating income covered its interest 13.2 times.
Borrowings to equity
0.54
$3.95B of borrowings on $7.36B of equity, Jul 2026
Interest cover
13.2x
operating income over interest, fiscal year to October 2025
Return on invested capital
13.2%
latest quarter to July 2026, annualised; the stock card's measure
Cash and borrowings at each fiscal year end
What the balance sheet holdsJuly 31, 2026
"Other liabilities" is total liabilities less borrowings and lease liabilities; "Property, goodwill and other" is total assets less the current assets and long-term investments.
Balance sheet, the last 10 fiscal year ends
| Fiscal year end | Latest Jul 2026 | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash and short-term investments | 1.8 | 1.8 | 1.3 | 1.6 | 1.1 | 1.6 | 1.4 | 1.4 | 2.2 | 2.7 | 2.3 |
| Receivables | 1.5 | 1.5 | 1.3 | 1.3 | 1.4 | 1.2 | 1.0 | 0.9 | 0.8 | 0.7 | 0.6 |
| Inventory | 1.1 | 1.0 | 1.0 | 1.0 | 1.0 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 |
| Other current assets | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Total current assets | 4.7 | 4.6 | 4.0 | 4.2 | 3.8 | 3.8 | 3.4 | 3.2 | 3.8 | 4.2 | 3.6 |
| Long-term investments | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Total assets | 14.0 | 12.7 | 11.8 | 10.8 | 10.5 | 10.7 | 9.6 | 9.5 | 8.5 | 8.4 | 7.8 |
| Liabilities and equity | |||||||||||
| Current liabilities | 2.3 | 2.3 | 1.9 | 1.6 | 1.9 | 1.7 | 1.5 | 2.1 | 1.2 | 1.3 | 0.9 |
| Borrowings | 3.9 | 3.4 | 3.4 | 2.7 | 2.8 | 2.7 | 2.4 | 2.4 | 1.8 | 2.0 | 1.9 |
| Lease liabilities | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | — | 0.0 | — | — | — |
| Total liabilities | 6.6 | 6.0 | 5.9 | 4.9 | 5.2 | 5.3 | 4.8 | 4.7 | 4.0 | 3.6 | 3.5 |
| Shareholders' equity | 7.4 | 6.7 | 5.9 | 5.8 | 5.3 | 5.4 | 4.9 | 4.7 | 4.6 | 4.8 | 4.2 |
| Financial health | |||||||||||
| Cash less borrowings | -2.2 | -1.6 | -2.1 | -1.1 | -1.7 | -1.2 | -0.9 | -1.0 | 0.4 | 0.7 | 0.4 |
| Borrowings to equity | 0.54 | 0.50 | 0.57 | 0.47 | 0.52 | 0.51 | 0.48 | 0.51 | 0.39 | 0.42 | 0.45 |
| Interest cover | — | 13.2x | 15.5x | 14.2x | 19.3x | 16.6x | 10.8x | 12.7x | 12.1x | 10.2x | 8.5x |
Interest cover is operating income over interest expense, for full fiscal years. Minority interests and other is total assets less total liabilities and shareholders' equity (calculated by TrendArc). Company filings as standardised by Tiingo; borrowings and lease liabilities told apart with the lines the company files on SEC EDGAR, and a dash where the two cannot be told apart. Rebuilt nightly.
Agilent Technologies against its peers
| Company | Cash less borrowings | Borrowings to equity | Interest cover | Return on invested capital |
|---|---|---|---|---|
| Bio-TechneTECH | +$150M | 0.09 | 26.2x | 5.1% |
| IlluminaILMN | -$452M | 0.57 | 8.0x | 16.4% |
| Mettler ToledoMTD | -$1.97B | 26.06 | 16.1x | 48.2% |
| Agilent TechnologiesA | -$2.19B | 0.54 | 13.2x | 13.2% |
| Charles River LaboratoriesCRL | -$2.24B | 0.76 | 0.2x | 21.9% |
| WatersWAT | -$4.54B | 0.34 | 11.5x | 1.6% |
| IQVIAIQV | -$13.6B | 2.41 | 3.0x | 6.4% |
Each company's newest balance sheet; borrowings leave lease liabilities out; interest cover for its newest fiscal year; return on invested capital is the stock card's measure. A dash where a measure does not apply.
Next
Follow Agilent Technologies with a free account.
A watchlist, price alerts and saved chart layouts. No card needed.
Sign up freeNo forecast, no recommendation. This page describes Agilent Technologies from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.
The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.